Paper Details

  1. Home
  2. Paper Details

Ofloxacin otic solution as treatment of chronic suppurative otitis media and diffuse bacterial otitis externa.

Author: IngsuwanB, PrawatmuangW, SriburiP, SumitsawanY, TharavichitkulP

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

Ofloxacin 0.3% was effective in controlling chronic suppurative otitis media and diffuse bacterial otitis externa. It was well tolerated and resulted in good clinical and bacteriological outcomes without significant side effects.
Paper Details　
Original Abstract of the Article :
Pseudomonas aeruginosa, Diphtheroid bacilli, Staphylococcus aureus were the major causes of diffuse bacteria otitis externa and chronic suppurative otitis media. This study showed that 0.3 per cent ofloxacin used for 2 weeks gave good clinical and bacteriological control of chronic suppurative otiti...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/7561571

データ提供：米国国立医学図書館（NLM）

Evaluating the Efficacy of Ofloxacin Otic Solution for Ear Infections

Ear infections are a common ailment, and finding effective treatments is crucial. This research investigated the effectiveness of 0.3% ofloxacin otic solution in treating chronic suppurative otitis media and diffuse bacterial otitis externa. The authors aimed to determine the clinical and bacteriological efficacy of this treatment approach. The study found that 0.3% ofloxacin otic solution, administered for two weeks, provided good clinical and bacteriological control of both chronic suppurative otitis media and diffuse bacterial otitis externa, without significant side effects. This research provides valuable insights into the potential of ofloxacin otic solution as a treatment option for these common ear infections.

The Importance of Effective Treatment Options for Ear Infections

This study highlights the importance of having effective treatment options for common ear infections. The authors demonstrated the efficacy of 0.3% ofloxacin otic solution in treating chronic suppurative otitis media and diffuse bacterial otitis externa, providing a potential solution for patients struggling with these conditions.

Navigating Ear Infections: Finding the Right Treatment

Ear infections can be a frustrating experience, and finding the right treatment is essential. This research suggests that 0.3% ofloxacin otic solution may be an effective treatment option for chronic suppurative otitis media and diffuse bacterial otitis externa. It is important to consult with your healthcare provider to determine the best treatment approach for your individual situation.

Dr.Camel's Conclusion

This research is like a camel traversing a vast desert, seeking a refreshing oasis to soothe its ears. The study highlights the effectiveness of ofloxacin otic solution in treating common ear infections, offering a potential oasis of relief for those struggling with these ailments. This research emphasizes the importance of seeking professional guidance and exploring effective treatment options to navigate the challenging journey of ear infections.

Date :
  1. Date Completed 1995-11-22
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

7561571

DOI: Digital Object Identifier

7561571

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.